Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 942

1.

Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium.

Yu JH, Appelbaum PS, Brothers KB, Joffe S, Kauffman TL, Koenig BA, Prince AE, Scollon S, Wolf SM, Bernhardt BA, Wilfond BS; Clinical Sequencing Exploratory Research (CSER) Consortium Informed Consent and Governance Working Group.

Per Med. 2019 Jul 17. doi: 10.2217/pme-2018-0076. [Epub ahead of print]

PMID:
31313633
2.

On What We Have Learned and Still Need to Learn about the Psychosocial Impacts of Genetic Testing.

Parens E, Appelbaum PS.

Hastings Cent Rep. 2019 May;49 Suppl 1:S2-S9. doi: 10.1002/hast.1011.

PMID:
31268574
3.

Dementia and the Death Penalty.

Appelbaum PS.

Psychiatr Serv. 2019 Jul 1;70(7):622-624. doi: 10.1176/appi.ps.70706.

PMID:
31258031
4.

Understanding Factors Associated with Uptake of BRCA1/2 Genetic Testing among Orthodox Jewish Women in the USA Using a Mixed-Methods Approach.

Trivedi MS, Colbeth H, Yi H, Vanegas A, Starck R, Chung WK, Appelbaum PS, Kukafka R, Schechter I, Crew KD.

Public Health Genomics. 2019 Jun 4:1-11. doi: 10.1159/000499852. [Epub ahead of print]

PMID:
31163445
5.

Including the blind community in precision medicine research: findings from a national survey and recommendations.

Sabatello M, Blake LA, Chao A, Silverman A, Ovadia Mazzoni R, Zhang Y, Chen Y, Appelbaum PS.

Genet Med. 2019 May 16. doi: 10.1038/s41436-019-0533-y. [Epub ahead of print]

PMID:
31092907
6.

Ignorance Isn't Bliss: Retaining a Meaningful Comprehension Requirement for Consent to Research.

Appelbaum PS.

Am J Bioeth. 2019 May;19(5):22-24. doi: 10.1080/15265161.2019.1587037. No abstract available.

PMID:
31090515
7.

Cases in Precision Medicine: Concerns About Privacy and Discrimination After Genomic Sequencing.

Stiles D, Appelbaum PS.

Ann Intern Med. 2019 May 7. doi: 10.7326/M18-2666. [Epub ahead of print]

PMID:
31060048
8.

Correction: Evaluation of the cost and effectiveness of diverse recruitment methods for a genetic screening study.

Rasouly HM, Wynn J, Marasa M, Reingold R, Chatterjee D, Kapoor S, Piva S, Kil BH, Mu X, Alvarez M, Nestor J, Mehl K, Revah-Politi A, Lippa N, Ernst ME, Bier L, Espinal A, Haser B, Sinha A, Halim I, Fasel D, Cuneo N, Thompson JJ, Verbitsky M, Cohn EG, Goldman J, Marder K, Klitzman RL, Orjuela MA, So YS, Fedotov A, Crew KD, Kiryluk K, Appelbaum PS, Weng C, Siegel K, Gharavi AG, Chung WK.

Genet Med. 2019 May 1. doi: 10.1038/s41436-019-0528-8. [Epub ahead of print]

PMID:
31040387
9.

How Single Institutional Review Boards Manage Their Own Conflicts of Interest: Findings From a National Interview Study.

Pivovarova E, Klitzman RL, Murray A, Stiles DF, Appelbaum PS, Lidz CW.

Acad Med. 2019 Apr 16. doi: 10.1097/ACM.0000000000002762. [Epub ahead of print]

PMID:
30998578
10.

Ten Years After the ADA Amendment Act (2008): The Relationship Between ADA Employment Discrimination and Substance Use Disorders.

Aoun EG, Appelbaum PS.

Psychiatr Serv. 2019 Jul 1;70(7):596-603. doi: 10.1176/appi.ps.201800574. Epub 2019 Apr 17.

PMID:
30991909
11.

Amygdalar volume and violent ideation in a sample at clinical high-risk for psychosis.

Feng X, Provenzano F, Appelbaum PS, Masucci MD, Brucato G, Lieberman JA, Girgis RR.

Psychiatry Res Neuroimaging. 2019 May 30;287:60-62. doi: 10.1016/j.pscychresns.2019.04.003. Epub 2019 Apr 11.

PMID:
30991249
12.

Are Placebo-Controlled, Relapse Prevention Trials in Schizophrenia Research Still Necessary or Ethical?

Lawrence RE, Appelbaum PS, Lieberman JA.

JAMA Psychiatry. 2019 Apr 10. doi: 10.1001/jamapsychiatry.2019.0275. [Epub ahead of print] No abstract available.

PMID:
30969331
13.

Evaluation of the cost and effectiveness of diverse recruitment methods for a genetic screening study.

Milo Rasouly H, Wynn J, Marasa M, Reingold R, Chatterjee D, Kapoor S, Piva S, Kil BH, Mu X, Alvarez M, Nestor J, Mehl K, Revah-Politi A, Lippa N, Ernst ME, Bier L, Espinal A, Haser B, Sinha A, Halim I, Fasel D, Cuneo N, Thompson JJ, Verbitsky M, Cohn EG, Goldman J, Marder K, Klitzman RL, Orjuela MA, So YS, Fedotov A, Crew KD, Kiryluk K, Appelbaum PS, Weng C, Siegel K, Gharavi AG, Chung WK.

Genet Med. 2019 Apr 1. doi: 10.1038/s41436-019-0497-y. [Epub ahead of print] Erratum in: Genet Med. 2019 May 1;:.

PMID:
30930462
14.

Disability inclusion in precision medicine research: a first national survey.

Sabatello M, Chen Y, Zhang Y, Appelbaum PS.

Genet Med. 2019 Mar 22. doi: 10.1038/s41436-019-0486-1. [Epub ahead of print]

PMID:
30899094
15.

Responsibility for Suicide or Violence on Campus.

Appelbaum PS.

Psychiatr Serv. 2019 Apr 1;70(4):350-352. doi: 10.1176/appi.ps.201900060. Epub 2019 Mar 7.

PMID:
30841841
16.

Decisional Capacity for Informed Consent in Males and Females with Fragile X Syndrome.

Wheeler AC, Wylie A, Raspa M, Villagomez A, Miller K, Edwards A, DeRamus M, Appelbaum PS, Bailey DB Jr.

J Autism Dev Disord. 2019 Mar 1. doi: 10.1007/s10803-019-03930-4. [Epub ahead of print]

PMID:
30825084
17.

Local Knowledge and Single IRBs for Multisite Studies: Challenges and Solutions.

Klitzman R, Pivovarova E, Murray A, Appelbaum PS, Stiles DF, Lidz CW.

Ethics Hum Res. 2019 Jan;41(1):22-31. doi: 10.1002/eahr.500003.

PMID:
30744311
18.

Saving the UN Convention on the Rights of Persons with Disabilities - from itself.

Appelbaum PS.

World Psychiatry. 2019 Feb;18(1):1-2. doi: 10.1002/wps.20583. No abstract available.

19.

Prevalence and phenomenology of violent ideation and behavior among 200 young people at clinical high-risk for psychosis: an emerging model of violence and psychotic illness.

Brucato G, Appelbaum PS, Masucci MD, Rolin S, Wall MM, Levin M, Altschuler R, First MB, Lieberman JA, Girgis RR.

Neuropsychopharmacology. 2019 Apr;44(5):907-914. doi: 10.1038/s41386-018-0304-5. Epub 2018 Dec 27.

PMID:
30591713
20.

Biomedical Explanations of Psychopathology and Their Implications for Attitudes and Beliefs About Mental Disorders.

Lebowitz MS, Appelbaum PS.

Annu Rev Clin Psychol. 2019 May 7;15:555-577. doi: 10.1146/annurev-clinpsy-050718-095416. Epub 2018 Nov 16.

PMID:
30444641
21.

Standardizing return of participant results.

Botkin JR, Appelbaum PS, Bakken S, Brown C, Burke W, Fabsitz R, Gamble VN, Gonsalves G, Kost R, Leonard DGB, McGuire A, Nichols JH, Patrick-Lake B, Wilkins CH, Zikmund-Fisher BJ.

Science. 2018 Nov 16;362(6416):759-760. doi: 10.1126/science.aav8095. Epub 2018 Nov 15. No abstract available.

PMID:
30442797
22.

Reliance agreements and single IRB review of multisite research: Concerns of IRB members and staff.

Lidz CW, Pivovarova E, Appelbaum P, Stiles DF, Murray A, Klitzman RL.

AJOB Empir Bioeth. 2018 Jul-Sep;9(3):164-172. doi: 10.1080/23294515.2018.1510437. Epub 2018 Oct 4.

PMID:
30285561
23.

Ordering Abstinence: How Far Can Courts Go in Requiring Offenders to Remain Substance Free?

Appelbaum PS.

Psychiatr Serv. 2018 Oct 1;69(10):1059-1061. doi: 10.1176/appi.ps.201800357.

PMID:
30277437
24.

The physician-patient relationship in the age of precision medicine.

Eyal G, Sabatello M, Tabb K, Adams R, Jones M, Lichtenberg FR, Nelson A, Ochsner K, Rowe J, Stiles D, Sivaramakrishnan K, Underhill K, Appelbaum PS.

Genet Med. 2019 Apr;21(4):813-815. doi: 10.1038/s41436-018-0286-z. Epub 2018 Sep 14. No abstract available.

PMID:
30214065
25.

Increasing genomic literacy among adolescents.

Sabatello M, Chen Y, Sanderson SC, Chung WK, Appelbaum PS.

Genet Med. 2019 Apr;21(4):994-1000. doi: 10.1038/s41436-018-0275-2. Epub 2018 Sep 14.

PMID:
30214064
26.

Correction to: Behavioral Genetics and Attributions of Moral Responsibility.

Tabb K, Lebowitz MS, Appelbaum PS.

Behav Genet. 2019 May;49(3):347. doi: 10.1007/s10519-018-9921-3.

PMID:
30196388
27.

Behavioral Genetics and Attributions of Moral Responsibility.

Tabb K, Lebowitz MS, Appelbaum PS.

Behav Genet. 2019 Mar;49(2):128-135. doi: 10.1007/s10519-018-9916-0. Epub 2018 Aug 9. Erratum in: Behav Genet. 2018 Sep 8;:.

PMID:
30094665
28.

A data-driven method for identifying shorter symptom criteria sets: the case for DSM-5 alcohol use disorder.

Raffo CD, Hasin DS, Appelbaum P, Wall MM.

Psychol Med. 2019 Apr;49(6):931-939. doi: 10.1017/S0033291718001551. Epub 2018 Jun 27.

PMID:
29947307
29.

Physician-assisted death in psychiatry.

Appelbaum PS.

World Psychiatry. 2018 Jun;17(2):145-146. doi: 10.1002/wps.20548. No abstract available.

30.

Deaths of people with mental illness during interactions with law enforcement.

Saleh AZ, Appelbaum PS, Liu X, Scott Stroup T, Wall M.

Int J Law Psychiatry. 2018 May - Jun;58:110-116. doi: 10.1016/j.ijlp.2018.03.003. Epub 2018 Apr 21.

PMID:
29853001
31.

Civil Commitment for Opioid and Other Substance Use Disorders: Does It Work?

Jain A, Christopher P, Appelbaum PS.

Psychiatr Serv. 2018 Apr 1;69(4):374-376. doi: 10.1176/appi.ps.201800066.

PMID:
29607774
32.

Use of Security Officers on Inpatient Psychiatry Units.

Lawrence RE, Perez-Coste MM, Arkow SD, Appelbaum PS, Dixon LB.

Psychiatr Serv. 2018 Jul 1;69(7):777-783. doi: 10.1176/appi.ps.201700546. Epub 2018 Apr 2.

PMID:
29606074
33.

Analysis of state laws on informed consent for clinical genetic testing in the era of genomic sequencing.

Spector-Bagdady K, Prince AER, Yu JH, Appelbaum PS.

Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):81-88. doi: 10.1002/ajmg.c.31608. Epub 2018 Mar 22.

34.

Physician-Assisted Death for Psychiatric Patients - Misguided Public Policy.

Miller FG, Appelbaum PS.

N Engl J Med. 2018 Mar 8;378(10):883-885. doi: 10.1056/NEJMp1709024. No abstract available.

PMID:
29514026
35.

Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision.

Chen DT, Ko TM, Allen AA, Bonnie RJ, Suratt CE, Appelbaum PS, Nunes EV, Friedmann PD, Lee JD, Gordon MS, McDonald R, Wilson D, Boney TY, Murphy SM, O'Brien CP.

J Empir Res Hum Res Ethics. 2018 Apr;13(2):160-172. doi: 10.1177/1556264618755243. Epub 2018 Feb 20.

PMID:
29460668
36.

Balancing autonomy and beneficence at the time of psychiatric discharge.

Jain A, Appelbaum PS.

Isr J Health Policy Res. 2018 Jan 2;7(1):2. doi: 10.1186/s13584-017-0201-0.

37.

Diagnostic exome sequencing in children: A survey of parental understanding, experience and psychological impact.

Wynn J, Ottman R, Duong J, Wilson AL, Ahimaz P, Martinez J, Rabin R, Rosen E, Webster R, Au C, Cho MT, Egan C, Guzman E, Primiano M, Shaw JE, Sisson R, Klitzman RL, Appelbaum PS, Lichter-Konecki U, Anyane-Yeboa K, Iglesias A, Chung WK.

Clin Genet. 2018 May;93(5):1039-1048. doi: 10.1111/cge.13200. Epub 2018 Mar 13.

38.

Behavioral Genetics in Criminal Court.

Scurich N, Appelbaum PS.

Nat Hum Behav. 2017;1:772-774. doi: 10.1038/s41562-017-0212-4. Epub 2017 Sep 18.

39.

Moving Toward the Future in the Diagnosis of Mental Disorders.

Appelbaum PS.

Psychol Sci Public Interest. 2017 Sep;18(2):67-71. doi: 10.1177/1529100617727267. No abstract available.

PMID:
29211975
40.

Forensic Experts, Indigent Defendants, and the Constitution.

Appelbaum PS.

Psychiatr Serv. 2018 Jan 1;69(1):2-4. doi: 10.1176/appi.ps.201700467. Epub 2017 Dec 1.

PMID:
29191142
41.

Impact of Receiving Secondary Results from Genomic Research: A 12-Month Longitudinal Study.

Wynn J, Martinez J, Bulafka J, Duong J, Zhang Y, Chiuzan C, Preti J, Cremona ML, Jobanputra V, Fyer AJ, Klitzman RL, Appelbaum PS, Chung WK.

J Genet Couns. 2018 Jun;27(3):709-722. doi: 10.1007/s10897-017-0172-x. Epub 2017 Nov 22.

42.

Behavioral Genetics in Criminal and Civil Courts.

Sabatello M, Appelbaum PS.

Harv Rev Psychiatry. 2017 Nov/Dec;25(6):289-301. doi: 10.1097/HRP.0000000000000141. Review.

43.

Beneficial and detrimental effects of genetic explanations for addiction.

Lebowitz MS, Appelbaum PS.

Int J Soc Psychiatry. 2017 Dec;63(8):717-723. doi: 10.1177/0020764017737573. Epub 2017 Oct 23.

44.

Reducing therapeutic misconception: A randomized intervention trial in hypothetical clinical trials.

Christopher PP, Appelbaum PS, Truong D, Albert K, Maranda L, Lidz C.

PLoS One. 2017 Sep 20;12(9):e0184224. doi: 10.1371/journal.pone.0184224. eCollection 2017.

45.

Mental Disorders as a Basis for Physician-Assisted Death: In Reply.

Appelbaum PS.

Psychiatr Serv. 2017 Sep 1;68(9):981-982. doi: 10.1176/appi.ps.68902. No abstract available.

PMID:
28862097
46.

Perceptions of control and unrealistic optimism in early-phase cancer trials.

Jansen LA, Mahadevan D, Appelbaum PS, Klein WMP, Weinstein ND, Mori M, Degnin C, Sulmasy DP.

J Med Ethics. 2018 Feb;44(2):121-127. doi: 10.1136/medethics-2016-103724. Epub 2017 Aug 3.

PMID:
28774957
47.

The Precision Medicine Nation.

Sabatello M, Appelbaum PS.

Hastings Cent Rep. 2017 Jul;47(4):19-29. doi: 10.1002/hast.736.

48.

A Longitudinal Study of Violent Behavior in a Psychosis-Risk Cohort.

Brucato G, Appelbaum PS, Lieberman JA, Wall MM, Feng T, Masucci MD, Altschuler R, Girgis RR.

Neuropsychopharmacology. 2018 Jan;43(2):264-271. doi: 10.1038/npp.2017.151. Epub 2017 Jul 26.

49.

Variations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials.

Jansen LA, Mahadevan D, Appelbaum PS, Klein WMP, Weinstein ND, Mori M, Degnin C, Sulmasy DP.

J Empir Res Hum Res Ethics. 2017 Oct;12(4):280-288. doi: 10.1177/1556264617720433. Epub 2017 Jul 21.

50.

Reflections on the Goldwater Rule.

Appelbaum PS.

J Am Acad Psychiatry Law. 2017 Jun;45(2):228-232.

PMID:
28619865

Supplemental Content

Loading ...
Support Center